Changes in pulmonary artery pressure in infants with respiratory distress syndrome after treatment with Exosurf.
Rogers
D
D
D004338:Drug Combinations; D005233:Fatty Alcohols / Q000009:adverse effects*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D010767:Phosphorylcholine; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011663:Pulmonary Surfactants / Q000009:adverse effects*; D011669:Pulmonary Wedge Pressure / Q000187:drug effects*; D012127:Respiratory Distress Syndrome, Newborn / Q000503:physiopathology*
D004338:Drug Combinations; D005233:Fatty Alcohols; D011663:Pulmonary Surfactants; D010767:Phosphorylcholine; D011092:Polyethylene Glycols; C047049:dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination